M. Malumbres and M. Barbacid, Cell cycle, CDKs and cancer: a changing paradigm, Nat Rev Cancer, vol.9, pp.153-166, 2009.

C. J. Sherr, D. Beach, and G. I. Shapiro, Targeting CDK4 and CDK6: From discovery to therapy, Cancer Discov, vol.6, pp.353-367, 2016.

M. C. Casimiro, M. Crosariol, and E. Loro, Cyclins and cell cycle control in cancer and disease, Genes Cancer, vol.3, pp.649-657, 2013.

R. Beroukhim, C. H. Mermel, and D. Porter, The landscape of somatic copy-number alteration across human cancers, Nature, vol.463, pp.899-905, 2010.

P. Hydbring, M. Malumbres, and P. Sicinski, Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases, Nat Rev Mol Cell Biol, vol.17, pp.280-292, 2016.

A. Mohanty, N. Sandoval, and M. Das, CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma, Oncotarget, vol.7, pp.73558-73572, 2016.

Z. Li, X. Jiao, and C. Wang, Alternative cyclin D1 splice forms differentially regulate the DNA damage response, Cancer Res, vol.70, pp.8802-8811, 2010.

S. Jirawatnotai, Y. Hu, and W. Michowski, A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers, Nature, vol.474, pp.230-234, 2011.

X. Zeng, F. Y. Shaikh, and M. K. Harrison, The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2, Oncogene, vol.29, pp.5103-5112, 2010.

M. C. Casimiro, M. Crosariol, and E. Loro, ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice, J Clin Invest, vol.122, pp.833-843, 2012.

N. E. Brown, R. Jeselsohn, and T. Bihani, Cyclin D1 activity regulates autophagy and senescence in the mammary epithelium, Cancer Res, vol.72, pp.6477-6489, 2012.

P. Laphanuwat, P. Likasitwatanakui, and G. Sittithumcharee, Cyclin D1 depletion interferes with oxidative balance and promotes cancer cell senescence, J Cell Sci, p.131, 2018.

M. C. Casimiro, D. Sante, G. , D. Rocco, and A. , Cyclin D1 restrains oncogene-induced autophagy by regulating the AMPK-LKB1 signaling axis, Cancer Res, vol.77, pp.3391-3405, 2017.

T. Sakamaki, M. C. Casiliro, and X. Ju, Cyclin D1 determines mitochondrial function in vivo, Mol Cell Biol, vol.26, pp.5449-5469, 2006.

G. Tchakarska, M. Roussel, and X. Troussard, Cyclin D1 inhibits mitochondrial activity in B cells, Cancer Res, vol.71, pp.1690-1699, 2011.

P. Neumeister, F. J. Pixley, and Y. Xiong, Cyclin D1 governs adhesion and motility of macrophages, Mol Biol Cell, vol.14, pp.20-25, 2003.

Z. Li, X. Jiao, and C. Wang, Cyclin D1 induction of cellular migration requires p27(KIP1), Cancer Res, vol.66, pp.9986-9994, 2006.

Z. Li, C. Wang, and X. Jiao, Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration, J Biol Chem, pp.7007-7015, 2008.

Y. Lee, J. E. Dominy, and Y. J. Choi, Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression, Nature, vol.510, pp.547-551, 2014.

S. Kamarajugadda, J. R. Becker, and E. A. Hanse, Cyclin D1 represses peroxisome proliferatoractivated receptor alpha and inhibits fatty acid oxidation, Oncotarget, vol.7, pp.47674-47686, 2016.

S. Qie, A. Yoshida, and S. Parnham, Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma, Nat Commun, vol.10, p.1296, 2019.

S. Goel, M. J. Decristo, and A. C. Watt, CDK4/6 inhibition triggers anti-tumour immunity, Nature, vol.548, pp.471-475, 2017.

J. Zhang, X. Bu, and H. Wang, Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance, Nature, vol.553, pp.91-95, 2018.

Z. Zhong, W. S. Yeow, and C. Zou, Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells, Cancer Res, vol.70, pp.2105-2114, 2010.

N. Bendris, B. Lemmers, and J. M. Blanchard, Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors, Cell Cycle, vol.14, pp.1786-1798, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02187383

S. Qie and J. A. Diehl, Cyclin D1, cancer progression, and opportunities in cancer treatment, J. Mol. Med, vol.94, pp.1313-1326, 2016.

T. Otto and P. Sicinski, Cell cycle proteins as promising targets in cancer therapy, Nat Rev Cancer, vol.17, pp.93-115, 2017.

J. A. Diehl, M. Cheng, and M. F. Roussel, Glycogen synthase kinase-3 beta regulates cyclin D1 proteolysis and subcellular localization, Genes Dev, vol.12, pp.3499-3511, 1998.

R. M. Densham, D. E. Todd, and K. Balmanno, ERK1/2 and p38 cooperate to delay progression through G1 by promoting cyclin D1 protein turnover, Cell Signal, vol.20, pp.1986-1994, 2008.

H. Okabe, S. Lee, and J. Phuchareon, A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation, PLoS One, vol.1, p.128, 2006.

M. K. Santra, N. Wajapeyee, and M. R. Green, F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage, Nature, vol.459, pp.722-725, 2009.

. Douglas-i-lin, O. Barbash, K. Kumar, J. D. Weber, J. W. Harper et al., Phosphorylation-Dependent Ubiquitinationof Cyclin D1 by the SCFFBX4-aB Crystallin Complex, Mol Cell, vol.24, pp.355-366, 2006.

O. Barbash, P. Zamfirova, and D. I. Lin, Mutations in Fbx4 inhibit dimerization of the SCFFbx4 ligase and contribute to cyclin D1 overexpression in human cancer, Cancer Cell, vol.14, pp.68-78, 2008.

L. P. Vaites, E. K. Lee, and Z. Lian, The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation, Mol Cell Biol, vol.31, pp.4513-4523, 2011.

M. I. Davis, R. Pragani, and J. T. Fox, Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models, J Biol Chem, vol.291, pp.24628-24640, 2016.

J. Shan, W. Zhao, and W. Gu, Suppression of cancer cell growth by promoting cyclin D1 degradation, Mol Cell, vol.36, pp.469-476, 2009.

M. A. Augello, C. J. Burd, and R. Birbe, Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes, J Clin Invest, vol.123, pp.493-508, 2012.

P. Ramos-garcía, M. Á. González-moles, and L. González-ruiz, Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis, Oral Oncol, vol.83, pp.96-106, 2018.

G. Capurso, S. Festa, and R. Valente, Molecular pathology and genetics of pancreatic endocrine tumours, J Mol Endocrinol, vol.49, pp.37-50, 2012.

M. C. Sini, V. Doneddu, and P. Paliogiannis, Genetic alterations in main candidate genes during melanoma progression, Oncotarget, vol.9, pp.8531-8541, 2018.

M. N. Khabaz, A. S. Abdelrahman, and N. S. Butt, Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients, Ann Diagn Pathol, vol.30, pp.47-51, 2017.

M. L. Slattery, J. S. Herrick, and L. E. Mullany, The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer, Genes Chromosomes Cancer, vol.56, pp.769-787, 2017.

J. George, J. S. Lim, and S. J. Jang, Comprehensive genomic profiles of small cell lung cancer, Nature, vol.524, pp.47-53, 2015.

N. Vogt, B. Dai, and T. Erdmann, The molecular pathogenesis of mantle cell lymphoma, Leuk Lymphoma, vol.58, pp.1530-1537, 2017.

E. A. Musgrove, C. E. Caldon, and J. Barraclough, Cyclin D as a therapeutic target in cancer, Nat Rev Cancer, vol.11, pp.558-572, 2011.

G. Moreno-bueno, S. Rodríguez-perales, and C. Sánchez-estévez, Cyclin D1 gene (CCND1) mutations in endometrial cancer, Oncogene, vol.22, pp.6115-6118, 2003.

S. Benzeno, F. Lu, and M. Guo, Identification of mutations that disrupt phosphorylationdependent nuclear export of cyclin D1, Oncogene, vol.25, pp.6291-6303, 2006.

A. Wiestner, M. Tehrani, and M. Chiorazzi, Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival, Blood, vol.109, pp.4599-4606, 2007.

A. Deshpande, A. Pastore, and A. J. Deshpande, UTR mediated regulation of the cyclin D1 proto-oncogene, Cell Cycle, vol.8, pp.3592-3600, 2014.

V. J. Gennaro, T. J. Stanek, and A. R. Peck, Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells, Proc Natl Acad Sci USA, vol.115, pp.9298-9307, 2018.

K. E. Knudsen, The cyclin D1b splice variant: an old oncogene learns new tricks, Cell Div, vol.1, p.15, 2006.

D. A. Solomon, Y. Wang, and S. R. Fox, Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation, J Biol Chem, vol.278, pp.30339-30347, 2003.

C. Comstock, M. A. Augello, and R. P. Benito, Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer, Clin Cancer Res, vol.15, pp.5338-5349, 2009.

C. Lévêque, V. Marsaud, and J. M. Renoir, Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes, Exp Cell Res, vol.313, pp.2719-2729, 2007.

F. Lu, A. B. Gladden, and J. A. Diehl, An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene, Cancer Res, vol.63, pp.7056-7051, 2003.

M. A. Augello, L. D. Berman-booty, and . Carr-r-3rd, Consequence of the tumor-associated conversion to cyclin D1b, EMBO Mol Med, vol.7, pp.628-647, 2015.

V. K. Gupta, A. Feber, and L. Xi, Association between CCND1 G/A870 polymorphism, allelespecific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma, Clin Cancer Res, vol.14, pp.7804-7812, 2008.

E. Millar, J. L. Dean, and C. M. Mcneil, Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome, Oncogene, vol.28, pp.1812-1820, 2009.

A. B. Gladden, R. Woolery, and P. Aggarwal, Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma, Oncogene, vol.25, pp.998-1007, 2005.

C. Comstock, M. P. Revelo, and C. R. Buncher, Impact of differential cyclin D1 expression and localisation in prostate cancer, Br J Cancer, vol.96, pp.970-979, 2007.

A. Fleischmann, C. Rocha, and N. Saxer-sekulic, High-level cytoplasmic cyclin D1 expression in lymph node metastases from prostate cancer independently predicts early biochemical failure and death in surgically treated patients, Histopathology, vol.58, pp.781-789, 2011.

N. P. Fusté, E. Castelblanco, and I. Felip, Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer, Oncotarget, vol.7, pp.26979-26991, 2016.

S. Body, A. Esteve-arenys, and H. Miloudi, Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells, Sci Rep, vol.7, p.13946, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01725070

T. Cemeli, M. Guasch-vallés, and M. Nàger, Cytoplasmic cyclin D1 regulates glioblastoma dissemination, J. Pathol, vol.248, pp.501-513, 2019.

C. J. Sherr and J. M. Roberts, Living with or without cyclins and cyclin-dependent kinases, Genes Dev, vol.18, pp.2699-2711, 2004.

E. A. Musgrove, Cyclins: roles in mitogenic signaling and oncogenic transformation, Growth Factors, vol.24, pp.13-19, 2006.

I. Matsuura, N. G. Denissova, and G. Wang, Cyclin-dependent kinases regulate the antiproliferative function of Smads, Nature, vol.430, pp.226-231, 2004.

L. Anders, N. Ke, and P. Hydbring, A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells, Cancer Cell, vol.20, pp.620-634, 2011.

F. Bienvenu, S. Jirawatnotai, and J. E. Elias, Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen, Nature, vol.463, pp.374-378, 2010.

F. Bienvenu, B. Barré, and S. Giraud, Transcriptional regulation by a DNA-associated form of cyclin D1, Mol Biol Cell, vol.16, pp.1850-1858, 2005.

R. G. Pestell, New roles of cyclin D1, Am J Pathol, vol.183, pp.3-9, 2013.

C. Mcmahon, T. Suthiphongchai, and J. Direnzo, P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor, Proc Natl Acad Sci USA, vol.96, pp.5382-5387, 1999.

J. Zhu, S. Sen, and C. Wei, Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor ?-mediated transcription, Int J Oncol, vol.36, pp.39-48, 2009.

C. E. Petre-draviam, E. B. Williams, and C. J. Burd, A central domain of cyclin D1 mediates nuclear receptor corepressor activity, Oncogene, vol.24, pp.431-444, 2004.

C. J. Burd, C. E. Petre, and H. Moghhadam, Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression, Mol Endocrinol, vol.19, pp.607-620, 2005.

M. Fu, M. Rao, and T. Bouras, Cyclin D1 inhibits peroxisome proliferator-activated receptor ?-mediated adipogenesis through histone deacetylase recruitment, J Biol Chem, vol.280, pp.16934-16941, 2005.

K. Inoue and E. A. Fry, Aberrant expression of cyclin D1 in cancer, Sign Transduct Insights, vol.4, pp.1-13, 2015.

S. Zhu, R. T. Mott, and E. A. Fry, Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer, Am J Pathol, vol.183, pp.1339-1350, 2013.

R. Albero, A. Enjuanes, and S. Demajo, Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasms, J Clin Invest, vol.128, pp.4132-4147, 2018.

Z. Li, X. Jiao, D. Sante, and G. , Cyclin D1 integrates G9a-mediated histone methylation, Oncogene, vol.38, pp.4232-4249, 2019.

G. Korkmaz, Z. Manber, and R. Lopes, A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation, Nucleic Acids Res, vol.47, pp.9557-9572, 2019.

A. Blackford, J. S. Atm, A. , and D. , The trinity at the heart of the DNA damage response, Mol Cell, vol.66, pp.801-817, 2017.

M. Pagano, A. M. Theodoras, and S. W. Tam, Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts, Genes Dev, vol.8, pp.1627-1639, 1994.

P. Aggarwal, M. D. Lessie, and D. I. Lin, Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication, Genes Dev, vol.21, pp.2908-2922, 2007.

T. Shimura, Y. Ochiai, and N. Noma, Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells, Cell Cycle, vol.12, pp.773-782, 2013.

L. L. Pontano, P. Aggarwal, and O. Barbash, Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability, Mol Cell Biol, vol.28, pp.7245-7258, 2008.

L. P. Vaites, Z. Lian, and E. K. Lee, ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis, Oncogene, vol.33, pp.129-133, 2013.

M. C. Casimiro, D. Sante, G. Crosariol, and M. , Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis, Oncotarget, vol.6, pp.8525-8538, 2015.

S. Jirawatnotai, Y. Hu, and D. M. Livingston, Proteomic identification of a direct role for cyclin D1 in DNA damage repair, Cancer Res, vol.72, pp.4289-4293, 2012.

F. Marampon, G. Gravina, and X. Ju, Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage, Oncotarget, vol.7, pp.5383-5400, 2016.

C. Wang, S. Fan, and Z. Li, Cyclin D1 antagonizes BRCA1 repression of estrogen receptor ? activity, Cancer Res, vol.65, pp.6557-6567, 2005.

C. Chalermrujinanant, W. Michowski, and G. Sittithumcharee, Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation, Oncogene, vol.35, pp.2815-2823, 2016.

Z. Li, K. Chen, and X. Jiao, Cyclin D1 integrates estrogen-mediated DNA damage signaling, Cancer Res, vol.74, pp.3959-3970, 2014.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011.

J. T. Parsons, A. R. Horwitz, and M. A. Schwartz, Cell adhesion: integrating cytoskeletal dynamics and cellular tension, Nat Rev Mol Cell Biol, vol.11, pp.633-643, 2010.

Z. Li, C. Wang, and X. Jiao, Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling, Mol Cell Biol, vol.26, pp.4240-4256, 2006.

N. P. Fusté, R. Fernández-hernández, and T. Cemeli, Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin, Nature Commun, vol.7, p.11581, 2016.

Z. Yu, C. Wang, and M. Wang, A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation, J Cell Biol, vol.182, pp.509-517, 2008.

Z. Yu, L. Wang, and C. Wang, Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer, Nature Commun, vol.4, p.2812, 2013.

K. Bhalla, W. J. Liu, and K. Thompson, Cyclin D1 represses gluconeogenesis via inhibition of the transcriptional coactivator PGC1, Diabetes, vol.63, pp.3266-3278, 2014.

E. A. Hanse, D. G. Mashek, and J. R. Becker, Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4?, Cell Cycle, vol.11, pp.2681-2690, 2012.

C. Wang, Z. Li, and Y. Lu, Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function, Proc Natl Acad Sci USA, vol.103, pp.11567-11572, 2006.

H. Wang, B. N. Nicolay, and J. M. Chick, The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival, Nature, vol.546, pp.426-430, 2017.

T. C. Wang, R. D. Cardiff, and L. Zukerberg, Mammary hyperplasia and carcinoma in MMTVcyclin D1 transgenic mice, Nature, vol.369, pp.669-671, 1994.

Q. Yu, Y. Geng, and P. Sicinski, Specific protection against breast cancers by cyclin D1 ablation, Nature, vol.411, pp.1017-1021, 2001.

Y. J. Choi, X. Li, and P. Hydbring, The requirement for cyclin D function in tumor maintenance, Cancer Cell, vol.22, pp.438-451, 2012.

M. W. Landis, B. S. Pawlyk, and T. Li, Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis, Cancer Cell, vol.9, pp.13-22, 2006.

Q. Yu, E. Sicinska, and Y. Geng, Requirement for CDK4 kinase function in breast cancer, Cancer Cell, vol.9, pp.23-32, 2006.

H. Lovec, A. Grzeschiczek, and M. B. Kowalski, Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice, EMBO J, vol.13, pp.3487-3495, 1994.

S. E. Bodrug, B. J. Warner, and M. L. Bath, Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene, EMBO J, vol.13, pp.2124-2130, 1994.

D. I. Lin, M. D. Lessie, and A. B. Gladden, Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis, Oncogene, vol.27, pp.1231-1242, 2007.

C. J. Kim, Y. Tambe, and K. Mukaisho, Female-specific rectal carcinogenesis in cyclin D1b transgenic mice, Carcinogenesis, vol.35, pp.227-236, 2014.

N. A. Olshavsky, C. E. Comstock, and M. J. Schiewer, Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene, Cancer Res, vol.70, pp.3975-3984, 2010.

M. P. Paronetto, M. Cappellari, and R. Busà, Alternative splicing of the cyclin D1 protooncogene is regulated by the RNA-binding protein Sam68, Cancer Res, vol.70, pp.229-239, 2010.

E. Batsché, M. Yaniv, and C. Muchardt, The human SWI/SNF subunit Brm is a regulator of alternative splicing, Nat Struct Mol Biol, vol.13, pp.22-29, 2005.

S. Jirawatnotai, S. Sharma, and W. Michowski, The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis, Cell Cycle, vol.13, pp.2889-2900, 2014.

B. O'leary, R. S. Finn, and N. C. Turner, Treating cancer with selective CDK4/6 inhibitors, Nat Rev Clin Oncol, vol.13, pp.417-430, 2016.

P. Aggarwal, L. P. Vaites, and J. K. Kim, Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase, Cancer Cell, vol.18, pp.329-340, 2010.

G. B. Liao, X. Z. Li, and S. Zeng, Regulation of the master regulator FOXM1 in cancer, Cell Commun Signal, vol.16, p.57, 2018.

R. M. Fernández, M. Ruiz-miró, and X. Dolcet, Cyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motility, Oncogene, vol.30, pp.1936-1946, 2011.

H. Meng, L. Tian, and J. Zhou, PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b, Cell Cycle, vol.10, pp.73-81, 2011.

S. Bustany, J. Cahu, and P. Guardiola, Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum stress-mediated apoptosis by activating the unfolded protein response pathway, BMC Cancer, vol.15, pp.262-273, 2015.

M. V. Kuleshov, M. R. Jones, and A. D. Rouillard, Enrichr: a comprehensive gene set enrichment analysis web server 2016 update, Nucleic Acids Res, vol.44, pp.90-97, 2016.

D. N. Slenter, M. Kutmon, and K. Hanspers, WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research, Nucleic Acids Res, vol.46, pp.661-667, 2017.